These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of fibrin structure in thrombosis and vascular disease. Cilia La Corte AL; Philippou H; Ariëns RA Adv Protein Chem Struct Biol; 2011; 83():75-127. PubMed ID: 21570666 [TBL] [Abstract][Full Text] [Related]
5. Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism. Martinez MR; Cuker A; Mills AM; Crichlow A; Lightfoot RT; Chernysh IN; Nagaswami C; Weisel JW; Ischiropoulos H Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L397-404. PubMed ID: 24414255 [TBL] [Abstract][Full Text] [Related]
6. Impact of fibrinogen carbamylation on fibrin clot formation and stability. Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370 [TBL] [Abstract][Full Text] [Related]
7. Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function. Duval C; Allan P; Connell SD; Ridger VC; Philippou H; Ariëns RA Thromb Haemost; 2014 May; 111(5):842-50. PubMed ID: 24430058 [TBL] [Abstract][Full Text] [Related]
8. Factor XIIIa incorporates thymosin beta4 preferentially into the fibrin(ogen) alphaC-domains. Makogonenko E; Goldstein AL; Bishop PD; Medved L Biochemistry; 2004 Aug; 43(33):10748-56. PubMed ID: 15311936 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics. Pechlivani N; Kearney KJ; Ajjan RA Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830419 [TBL] [Abstract][Full Text] [Related]
10. Genetic Variants in the Simurda T; Brunclikova M; Asselta R; Caccia S; Zolkova J; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610551 [TBL] [Abstract][Full Text] [Related]
16. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis? Bouma BN; Mosnier LO Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302 [TBL] [Abstract][Full Text] [Related]
17. A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3. Hess K; Alzahrani SH; Mathai M; Schroeder V; Carter AM; Howell G; Koko T; Strachan MW; Price JF; Smith KA; Grant PJ; Ajjan RA Diabetologia; 2012 Apr; 55(4):1103-13. PubMed ID: 21918806 [TBL] [Abstract][Full Text] [Related]